Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.5 NOK | -5.97% | +0.96% | +27.02% |
Mar. 05 | Transcript : Nordhealth AS, Q4 2023 Earnings Call, Mar 05, 2024 | |
Mar. 05 | Nordhealth AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 44.94M 48.65M 525M | Sales 2025 * | 53.23M 57.63M 622M | Capitalization | 213M 230M 2.48B |
---|---|---|---|---|---|
Net income 2024 * | -7M -7.58M -81.76M | Net income 2025 * | -1M -1.08M -11.68M | EV / Sales 2024 * | 4.18 x |
Net cash position 2024 * | 24.7M 26.74M 289M | Net cash position 2025 * | 29.22M 31.63M 341M | EV / Sales 2025 * | 3.45 x |
P/E ratio 2024 * |
-26.9
x | P/E ratio 2025 * |
-135
x | Employees | 385 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.53% |
Latest transcript on Nordhealth
1 day | -5.97% | ||
1 week | +0.96% | ||
Current month | -3.67% | ||
1 month | -4.83% | ||
3 months | +24.02% | ||
6 months | +33.47% | ||
Current year | +27.02% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 00-12-31 | |
Chief Executive Officer | - | 17-12-31 | |
Director of Finance/CFO | - | 22-01-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Didier Breton
CHM | Chairman | 71 | 20-12-31 |
Philippe Vimard
BRD | Director/Board Member | 50 | 23-04-23 |
Founder | - | 00-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 31.5 | -5.97% | 201 |
24-05-13 | 33.5 | +11.30% | 863 |
24-05-10 | 30.1 | -8.51% | 2,475 |
24-05-08 | 32.9 | +5.45% | 3,445 |
24-05-07 | 31.2 | +5.76% | 100,003 |
Real-time Oslo Bors, May 14, 2024 at 10:45 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.02% | 245M | |
+5.87% | 32.95B | |
+21.49% | 7.82B | |
+32.81% | 4.17B | |
-27.79% | 2.72B | |
-32.48% | 1.15B | |
+10.53% | 980M | |
-36.79% | 873M | |
-28.50% | 831M | |
-15.67% | 688M |
- Stock Market
- Equities
- NORDH Stock